TY - JOUR
T1 - Canadian Guidelines for the Assessment and Diagnosis of Patients with Schizophrenia Spectrum and Other Psychotic Disorders
AU - Addington, Donald
AU - Abidi, Sabina
AU - Garcia-Ortega, Iliana
AU - Honer, William G.
AU - Ismail, Zahinoor
N1 - Publisher Copyright:
© The Author(s) 2017.
PY - 2017/9/1
Y1 - 2017/9/1
N2 - Objective: The objective of this article is to identify best practices in the diagnosis and assessment of patients with schizophrenia spectrum and other psychotic disorders. The diagnosis and assessment may occur in a range of situations from the emergency room to the outpatient clinic and at different stages of the disorder. The focus may be on acute exacerbations of illness, residual symptoms, levels of function, or changes in the response to treatment. Methods: A systematic search was conducted for guidelines published in the last 5 years for schizophrenia and schizophrenia spectrum disorders. The guidelines were rated by at least 2 raters, and recommendations adopted on the diagnosis and assessment were primarily drawn from the American Psychiatric Association practice guidelines for the psychiatric evaluation of adults and the National Institute for Health and Care Excellence guideline on psychosis and schizophrenia in adults. A number of de novo recommendations were also developed. Results: Eleven recommendations were identified that cover a range of assessment situations from diagnosis to the involvement of families in assessments. Conclusions: An accurate assessment establishes the baseline for treatment planning based on clinical decision making for both pharmacotherapy and psychosocial treatments.
AB - Objective: The objective of this article is to identify best practices in the diagnosis and assessment of patients with schizophrenia spectrum and other psychotic disorders. The diagnosis and assessment may occur in a range of situations from the emergency room to the outpatient clinic and at different stages of the disorder. The focus may be on acute exacerbations of illness, residual symptoms, levels of function, or changes in the response to treatment. Methods: A systematic search was conducted for guidelines published in the last 5 years for schizophrenia and schizophrenia spectrum disorders. The guidelines were rated by at least 2 raters, and recommendations adopted on the diagnosis and assessment were primarily drawn from the American Psychiatric Association practice guidelines for the psychiatric evaluation of adults and the National Institute for Health and Care Excellence guideline on psychosis and schizophrenia in adults. A number of de novo recommendations were also developed. Results: Eleven recommendations were identified that cover a range of assessment situations from diagnosis to the involvement of families in assessments. Conclusions: An accurate assessment establishes the baseline for treatment planning based on clinical decision making for both pharmacotherapy and psychosocial treatments.
UR - http://www.scopus.com/inward/record.url?scp=85029059909&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029059909&partnerID=8YFLogxK
U2 - 10.1177/0706743717719899
DO - 10.1177/0706743717719899
M3 - Review article
C2 - 28730847
AN - SCOPUS:85029059909
SN - 0706-7437
VL - 62
SP - 594
EP - 603
JO - Canadian Journal of Psychiatry
JF - Canadian Journal of Psychiatry
IS - 9
ER -